- Home
- WWR vs RNXT Comparison
WWR vs RNXT Comparison
Compare WWR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWR
- RNXT
- Stock Information
- Founded
- WWR 1977
- RNXT 2012
- Country
- WWR United States
- RNXT United States
- Employees
- WWR N/A
- RNXT N/A
- Industry
- WWR Metal Mining
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- WWR Basic Materials
- RNXT Health Care
- Exchange
- WWR Nasdaq
- RNXT Nasdaq
- Market Cap
- WWR N/A
- RNXT 44.6M
- IPO Year
- WWR N/A
- RNXT 2021
- Fundamental
- Price
- WWR $0.59
- RNXT $1.30
- Analyst Decision
- WWR Strong Buy
- RNXT Strong Buy
- Analyst Count
- WWR 1
- RNXT 2
- Target Price
- WWR $2.00
- RNXT $7.25
- AVG Volume (30 Days)
- WWR 611.9K
- RNXT 140.4K
- Earning Date
- WWR 08-13-2025
- RNXT 08-12-2025
- Dividend Yield
- WWR N/A
- RNXT N/A
- EPS Growth
- WWR N/A
- RNXT N/A
- EPS
- WWR N/A
- RNXT N/A
- Revenue
- WWR N/A
- RNXT $240,000.00
- Revenue This Year
- WWR N/A
- RNXT $3,104.65
- Revenue Next Year
- WWR N/A
- RNXT $301.89
- P/E Ratio
- WWR N/A
- RNXT N/A
- Revenue Growth
- WWR N/A
- RNXT N/A
- 52 Week Low
- WWR $0.45
- RNXT $0.75
- 52 Week High
- WWR $1.32
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- WWR 58.04
- RNXT 53.41
- Support Level
- WWR $0.59
- RNXT $1.29
- Resistance Level
- WWR $0.63
- RNXT $1.38
- Average True Range (ATR)
- WWR 0.03
- RNXT 0.07
- MACD
- WWR -0.00
- RNXT -0.01
- Stochastic Oscillator
- WWR 50.00
- RNXT 48.39
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.